Human B7-H3/CD276 ELISA Kit0 Publications

カタログ番号: KE00143

51,000円

(希望販売価格)

容量: 1 Kit (96 assays)

販売および在庫状況はコスモ・バイオ(株)にお問い合わせください。
distributor

Images See all

概要


製品名:
Human B7-H3/CD276 ELISA Kit

試験方法:
1 X 96 well plate

測定サンプル対象:
Serum, Plasma, Cell culture supernatants, Cell lysates, Urine

アッセイ方法:
Sandwich

感度:
0.6 pg/mL

測定範囲:
9.4-600 pg/mL

測定可能動物種:
Human

適用アプリケーション:
Sandwich ELISA

回収率:
Sample TypeAverageRange
Human plasma 85% 77%-93%
urine 87% 79%-97%
Cell culture supernatants 88% 76%-104%
cell lysates 88% 75%-101%

IntraAssay:
Samplenmean (pg/mL)SDCV%
1 20 289.4 8.5 2.9
2 20 60.4 1.3 2.1
3 20 14.2 0.4 2.5

InterAssay:
Samplenmean (pg/mL)SDCV%
1 24 289.0 10.3 3.6
2 24 60.1 1.7 2.9
3 24 14.3 0.6 4.4

製品概要
KE00143 is a solid phase sandwich Enzyme Linked-Immuno-Sorbent Assay (Sandwich ELISA). The B7-H3/CD276 ELISA kit is to be used to detect and quantify protein levels of endogenous B7-H3/CD276. The assay recognizes human B7-H3/CD276. An antibody specific for B7-H3/CD276 has been pre-coated onto the microwells. The B7-H3/CD276 protein in samples is captured by the coated antibody after incubation. Following extensive washing, another horseradish peroxidase (HRP)-conjugated antibody specific for B7-H3/CD276 is added to detect the captured B7-H3/CD276 protein. For signal development, followed by Tetramethyl-benzidine (TMB) reagent. Solution containing sulfuric acid is used to stop color development and the color intensity which is proportional to the quantity of bound protein is measurable at 450nm with the correction wavelength set at 630 nm .

製品特性


保存方法:
All the reagents are stored at 2-8℃. Refer to the protocol for further storage instructions.

別名:
4Ig B7 H3, B7 H3, B7 homolog 3, B7H3, CD276, CD276 antigen, CD276 molecule, Costimulatory molecule, UNQ309/PRO352
背景説明

B7-H3 (CD276) is a type I transmembrane protein expressed on many tissues and cell types. B7-H3 is a 100-kDa glycoprotein that belongs to the B7 immunoregulatory family and participates in the regulation of T-cell-mediated immune response probably by functioning as both a T cell costimulator and coinhibitor. Overexpressed on a wide range of human solid cancers, B7-H3 has been implicated in cancer progression and metastasis and becomes an attractive target for cancer immunotherapy. Soluble form of B7-H3 (sB7-H3), released by monocytes, dendritic cells, activated T cells, and B7-H3-positive tumor cells, has been detected in human blood samples and cell culture supernatants.


Back
to top